Jim Tananbaum has made a name for himself when it comes to making massive investments in the healthcare sector. In fact, a recent interview with Ideamensch revealed that he has been a healthcare investment strategist and entrepreneur for over 25 years. This level of experience allowed him to come up with Foresite Capital Management.
A typical day for Jim mainly involves calls and meetings with members of his team. Meetings are split between various activities such as networking with healthcare thought leaders, discussing new company presentations and existing portfolio company updates. Jim Tananbaum also loves spending time with his family. In fact, he cited in the interview that his favorite family time activity was having dinner with his family.
Jim Tananbaum believes that he is an academic at heart despite his focus on investment and business. He attributes his love for learning to the drive behind finding the brightest and best solutions science can provide. Jim combined that passion with his unwavering commitment and persistence to establish Foresite Capital, as well as expand its innovative portfolio.
Jim Tananbaum has proven to be an avid businessman and entrepreneur, especially when it comes to founding successful healthcare business. Currently, he is acknowledged for being the CEO and founder of Foresite Capital Management. He came up with the healthcare-oriented private equity company driven by his mission to specialize on spotting emerging healthcare leaders, which in turn the firm would help grow to profitability through information, networks and capital supply. Jim steers Foresite into investing in companies not only with disruptive but also late-stage products and services in various sectors of healthcare such as diagnostics, genomics, biotechnology, medical devices and healthcare services.
Jim is acknowledged for co-founding two healthcare investment practices and two leading biopharmaceutical companies before founding Foresite. He is also known for spearheading investments in 21 healthcare companies like Amerigroup, Jazz Pharmaceuticals and Amira Pharmaceuticals, which was acquired by Bristol-Myers Squibb. Aside from having a successful business track record, Jim Tananbaum has an impressive education background. He is a proud holder of an MBA from Harvard Business School, an MD from Harvard Medical School and a B.S.E.E and B.S from Yale University.